PT1255535E - Composicao farmaceutica de libertacao controlada contendo cloridrato de tramadol - Google Patents

Composicao farmaceutica de libertacao controlada contendo cloridrato de tramadol

Info

Publication number
PT1255535E
PT1255535E PT00987947T PT00987947T PT1255535E PT 1255535 E PT1255535 E PT 1255535E PT 00987947 T PT00987947 T PT 00987947T PT 00987947 T PT00987947 T PT 00987947T PT 1255535 E PT1255535 E PT 1255535E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
composition containing
chloridrate
containing tramadol
controlled liberation
Prior art date
Application number
PT00987947T
Other languages
English (en)
Inventor
L Uboslav Razus
Helena Sedlarov
Ivan Varga
Ondrej Gattnar
Marian Zemanek
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Publication of PT1255535E publication Critical patent/PT1255535E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT00987947T 1999-12-28 2000-12-20 Composicao farmaceutica de libertacao controlada contendo cloridrato de tramadol PT1255535E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Publications (1)

Publication Number Publication Date
PT1255535E true PT1255535E (pt) 2006-09-29

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00987947T PT1255535E (pt) 1999-12-28 2000-12-20 Composicao farmaceutica de libertacao controlada contendo cloridrato de tramadol

Country Status (25)

Country Link
US (1) US20030175343A1 (pt)
EP (1) EP1255535B1 (pt)
JP (1) JP2003518486A (pt)
AT (1) ATE324103T1 (pt)
AU (1) AU2421601A (pt)
BG (1) BG65713B1 (pt)
CA (1) CA2397942C (pt)
CY (1) CY1106127T1 (pt)
CZ (1) CZ297394B6 (pt)
DE (1) DE60027601T2 (pt)
DK (1) DK1255535T3 (pt)
EA (1) EA006438B1 (pt)
EE (1) EE05231B1 (pt)
ES (1) ES2266018T3 (pt)
GE (1) GEP20053532B (pt)
HU (1) HUP0203842A3 (pt)
LT (1) LT5033B (pt)
LV (1) LV12917B (pt)
PL (1) PL208096B1 (pt)
PT (1) PT1255535E (pt)
SI (1) SI1255535T1 (pt)
SK (1) SK285128B6 (pt)
TW (1) TWI221419B (pt)
UA (1) UA76411C2 (pt)
WO (1) WO2001047497A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
PL1651248T3 (pl) * 2003-07-11 2010-02-26 Novartis Ag Doustnie dawkowana kompozycja farmaceutyczna zawierająca środek dostarczający w postaci mikronizowanej
US20080274264A1 (en) * 2006-06-09 2008-11-06 John Godber Calcium fortification substance for clear beverages
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
EP0654263B1 (en) 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
CA2397942A1 (en) 2001-07-05
BG106952A (en) 2003-03-31
ATE324103T1 (de) 2006-05-15
ES2266018T3 (es) 2007-03-01
HUP0203842A3 (en) 2004-06-28
BG65713B1 (bg) 2009-08-31
WO2001047497A3 (en) 2002-09-12
EA200200720A1 (ru) 2003-02-27
EE05231B1 (et) 2009-12-15
HUP0203842A2 (hu) 2003-05-28
EP1255535A2 (en) 2002-11-13
AU2421601A (en) 2001-07-09
SI1255535T1 (sl) 2006-10-31
SK186899A3 (en) 2001-07-10
CY1106127T1 (el) 2011-06-08
UA76411C2 (en) 2006-08-15
GEP20053532B (en) 2005-05-25
DK1255535T3 (da) 2006-08-28
JP2003518486A (ja) 2003-06-10
EE200200368A (et) 2003-10-15
CZ20022371A3 (cs) 2002-10-16
LV12917B (en) 2003-02-20
DE60027601T2 (de) 2007-04-26
PL208096B1 (pl) 2011-03-31
PL357680A1 (en) 2004-07-26
LT2002078A (en) 2003-03-25
SK285128B6 (sk) 2006-07-07
TWI221419B (en) 2004-10-01
DE60027601D1 (de) 2006-06-01
WO2001047497A2 (en) 2001-07-05
EP1255535B1 (en) 2006-04-26
EA006438B1 (ru) 2005-12-29
CA2397942C (en) 2008-07-15
US20030175343A1 (en) 2003-09-18
CZ297394B6 (cs) 2006-12-13
LT5033B (lt) 2003-07-25

Similar Documents

Publication Publication Date Title
CY1106127T1 (el) Φαρμακευτικη συσταση ελεγχομενης αποδεσμευσης που πepιεχει υδροχλωρικη τραμαδολη
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
IL111647A (en) Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
WO2005063218A3 (en) Pharmaceutical formulations of bisphosphonates
YU76503A (sh) Farmaceutski aktivni estri uridina
MY127430A (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
MY151470A (en) Controlled release solid preparation
HUP0204513A3 (en) Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
CY1115401T1 (el) Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης
MY129437A (en) Drug formulation having controlled release of active compound
MY138975A (en) Novel preparation and administration form comprising an acid-labile active compound
CO5170438A1 (es) Proceso para la preparacion de un comprimido de betahistina de liberacion controlada por granulacion en estado fundido y comprimido de liberacion controlada de betahistina obtenido mediante dicho proceso
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
EP1153611A3 (en) Pharmaceutical composition for the treatment of fibrosis
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
AU2003219641A1 (en) Analgesical oral composition with controlled release of an opioid